AI Summary
Thinking
Thinking
We reviewed 3 live results for cellex photopheresis and narrowed them down to the 3 options that look most worth comparing first.
The options are Immunology, THERAKOS® CELLEX® Photopheresis System and THERAKOS™ CELLEX™ Photopheresis System.
Source: Abu Dhabi Stem Cells Center
Description
The Department of Immunology at Abu Dhabi Stem Cells Center (ADSCC) provides comprehensive, personalized care and diagnosis for adult patients with immune system disorders, autoimmune diseases, immunodeficiencies, allergies, and inflammatory conditions. Clinical services include advanced apheresis, extracorporeal photopheresis (ECP) for cutaneous T-cell lymphoma and graft-versus-host disease, cytapheresis, biologics, and participation in clinical trials.
Best for
Adult patients with immunologic disorders, Patients with autoimmune diseases or allergies, Diagnosing and managing complex immune system disorders and Receiving advanced apheresis or extracorporeal photopheresis therapy
Rate this product
Source: Therakos
Description
The THERAKOS CELLEX Photopheresis System is an FDA-approved medical platform specifically designed for extracorporeal photopheresis administration. Developed for the palliative treatment of skin manifestations of Cutaneous T-Cell Lymphoma unresponsive to other therapies, it operates via single-needle or double-needle modes. The fully integrated closed system incorporates automated photosensitizing agent dosing calculations using UVADEX methoxsalen sterile solution, automated buffy coat collection, centrifuge cell separation, and UVA light photoactivation in both inpatient and outpatient healthcare environments.
Best for
Healthcare professionals, Oncologists, Extracorporeal photopheresis therapy and Palliative treatment of cutaneous T-cell lymphoma skin manifestations
Rate this product
Source: Therakos
Description
The THERAKOS CELLEX Photopheresis System is an integrated medical device designed for extracorporeal photopheresis (ECP) immunomodulation procedures. Featuring automated collection, photoactivation, and reinfusion within a single uninterrupted sterile fluid path, it offers single- and double-needle operation modes. Certified under EU Medical Device Regulation (EU MDR) 2017/745, the system is indicated for cutaneous T-cell lymphoma and solid organ transplant rejection in adults, as well as acute and chronic graft-versus-host disease in pediatric and adult patients aged three and older.
Best for
Healthcare professionals, Hospitals and photopheresis treatment centres, Extracorporeal photopheresis (ECP) therapy and Immunomodulation treatment for CTCL, solid organ transplant rejection, and GvHD
Rate this product
| Compare | #1Immunology | #2THERAKOS® CELLEX® Photopheresis System | #3THERAKOS™ CELLEX™ Photopheresis System |
|---|---|---|---|
| Source | Abu Dhabi Stem Cells Center | Therakos | Therakos |
| Description | The Department of Immunology at Abu Dhabi Stem Cells Center (ADSCC) provides comprehensive, personalized care and diagnosis for adult patients with immune system disorders, autoimmune diseases, immunodeficiencies, allergies, and inflammatory conditions. Clinical services include advanced apheresis, extracorporeal photopheresis (ECP) for cutaneous T-cell lymphoma and graft-versus-host disease, cytapheresis, biologics, and participation in clinical trials. | The THERAKOS CELLEX Photopheresis System is an FDA-approved medical platform specifically designed for extracorporeal photopheresis administration. Developed for the palliative treatment of skin manifestations of Cutaneous T-Cell Lymphoma unresponsive to other therapies, it operates via single-needle or double-needle modes. The fully integrated closed system incorporates automated photosensitizing agent dosing calculations using UVADEX methoxsalen sterile solution, automated buffy coat collection, centrifuge cell separation, and UVA light photoactivation in both inpatient and outpatient healthcare environments. | The THERAKOS CELLEX Photopheresis System is an integrated medical device designed for extracorporeal photopheresis (ECP) immunomodulation procedures. Featuring automated collection, photoactivation, and reinfusion within a single uninterrupted sterile fluid path, it offers single- and double-needle operation modes. Certified under EU Medical Device Regulation (EU MDR) 2017/745, the system is indicated for cutaneous T-cell lymphoma and solid organ transplant rejection in adults, as well as acute and chronic graft-versus-host disease in pediatric and adult patients aged three and older. |
| Best for | Adult patients with immunologic disorders, Patients with autoimmune diseases or allergies, Diagnosing and managing complex immune system disorders and Receiving advanced apheresis or extracorporeal photopheresis therapy | Healthcare professionals, Oncologists, Extracorporeal photopheresis therapy and Palliative treatment of cutaneous T-cell lymphoma skin manifestations | Healthcare professionals, Hospitals and photopheresis treatment centres, Extracorporeal photopheresis (ECP) therapy and Immunomodulation treatment for CTCL, solid organ transplant rejection, and GvHD |
| Action | Abu Dhabi Stem Cells Center | Therakos | Therakos |
| Rate this product |
"Immunology from Abu Dhabi Stem Cells Center."
Note: TopFind AI compiles product and service information for general comparison purposes only.